These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 17487295)

  • 1. Should we inhibit angiotensin-converting enzymes in acute heart failure?
    Lamond NW; Howlett JG
    Heart Fail Monit; 2007; 5(3):70-6. PubMed ID: 17487295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute decompensated heart failure: best evidence and current practice.
    Mehta R; Feldman D
    Minerva Cardioangiol; 2005 Dec; 53(6):537-47. PubMed ID: 16333237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and novel pharmacological approaches to renal insufficiency in heart failure.
    Hindnavis V; Tang WH
    Minerva Cardioangiol; 2006 Dec; 54(6):753-62. PubMed ID: 17167387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic stabilization and management of acute heart failure syndromes in the emergency department.
    Kirk JD; Parissis JT; Filippatos G
    Heart Fail Clin; 2009 Jan; 5(1):43-54, vi. PubMed ID: 19026385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based drug treatment of heart failure.
    Wasson S; Fleming D; Reddy HK
    Mo Med; 2005; 102(6):540-8; quiz 548-9. PubMed ID: 16355640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type natriuretic peptide: from bench to bedside.
    Adams KF; Mathur VS; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S34-46. PubMed ID: 12594450
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker adherence in patients with primary versus secondary diagnosis of heart failure.
    Brackbill ML; Bashaw-Keaton R; Sytsma CS
    Am J Manag Care; 2007 Oct; 13(10):568-70. PubMed ID: 17927461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy after hospital discharge on subsequent rehospitalization for acute myocardial infarction and heart failure.
    Hess G; Preblick R; Hill J; Plauschinat CA; Yaskin J
    Congest Heart Fail; 2009; 15(4):170-5. PubMed ID: 19627290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of current noninodilator therapies for acute heart failure syndromes.
    Stough WG; O'Connor CM; Gheorghiade M
    Am J Cardiol; 2005 Sep; 96(6A):41G-6G. PubMed ID: 16181822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug therapy for chronic heart failure due to left ventricular systolic dysfunction: a review. III. Angiotensin-converting enzyme inhibitors.
    Ascenção R; Fortuna P; Reis I; Carneiro AV
    Rev Port Cardiol; 2008 Sep; 27(9):1169-87. PubMed ID: 19044179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute decompensated heart failure: challenges and opportunities.
    Fonarow GC
    Rev Cardiovasc Med; 2007; 8 Suppl 5():S3-12. PubMed ID: 18192951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute congestive heart failure in the emergency department.
    Rogers RL; Feller ED; Gottlieb SS
    Cardiol Clin; 2006 Feb; 24(1):115-23, vii. PubMed ID: 16326261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of chronic heart failure: an old disease with a new face.
    Prendergast HM; Bunney EB
    Emerg Med Australas; 2005 Apr; 17(2):143-51. PubMed ID: 15796729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing treatment of chronic decompensated heart failure in the outpatient setting.
    Silver MA
    Rev Cardiovasc Med; 2004; 5 Suppl 4():S28-36. PubMed ID: 15627916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of fosinopril on the rate of neurohumoral and proinflammatory activation in patients with heart failure].
    Berezin AE
    Klin Med (Mosk); 2004; 82(9):29-32. PubMed ID: 15540418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Captopril in the treatment of heart failure].
    Kékes E
    Acta Pharm Hung; 1997 Jul; 67(4):155-63. PubMed ID: 9289944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.
    Munger MA; Ng TM; Van Tassell BW
    Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sublingual captopril: indications and advantages?].
    Meyer GJ
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S4. PubMed ID: 10818992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.